This work was supported by a grant from the EB-NCRC (grant no. R15-2003-012-01001-0) and (grant no. R01-2007-000-20299-0) supported by the KSEF/MOST of Korea. BODIPY=4,4-difluoro-4-bora-3a,4a-diaza-s-indacene.
Communication
A Selective Fluoroionophore Based on BODIPY-functionalized Magnetic Silica Nanoparticles: Removal of Pb2+ from Human Blood†
Article first published online: 7 JAN 2009
DOI: 10.1002/anie.200804714
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Additional Information
How to Cite
Lee, H., Bae, D., Park, J., Song, H., Han, W. and Jung, J. (2009), A Selective Fluoroionophore Based on BODIPY-functionalized Magnetic Silica Nanoparticles: Removal of Pb2+ from Human Blood. Angew. Chem. Int. Ed., 48: 1239–1243. doi: 10.1002/anie.200804714
- †
Publication History
- Issue published online: 28 JAN 2009
- Article first published online: 7 JAN 2009
- Manuscript Revised: 10 DEC 2008
- Manuscript Received: 26 SEP 2008
Funded by
- EB-NCRC. Grant Numbers: R15-2003-012-01001-0, R01-2007-000-20299-0
- KSEF/MOST
Keywords:
- blood;
- chemosensors;
- fluorescence;
- lead;
- nanoparticles
Abstract

Get the lead out: The title fluorescence receptor exhibits a high affinity and selectivity for Pb2+ over competing metal ions in water (see picture) with an overall emission change of approximately 8-fold at the emission maximum for Pb2+. The fluorescence receptor can remove 96 % of 100 ppb Pb2+ from human blood, and can be useful and effective for the selective and rapid removal of Pb2+ in vivo.

1521-3773/asset/2002_left.gif?v=1&s=ac6b0d94a94d7ce7a210002b8096b42feffc0bcf)
1521-3773/asset/olbannercenter.gif?v=1&s=c083e1920cd41ed129901c116018eab93b5ad3c4)
1521-3773/asset/2002_right.gif?v=1&s=451042aa3415ae3ad0729984d26dee1866aca82e)
1521-3773/asset/cover.gif?v=1&s=412bc65bdcb3f0e34a94f27c1c13e908726694d4)